This is an IHeart podcast.

Welcome to the Tudor Dixon podcast. I'm excited today. We have a senior advisor for clinical sciences at the U.S. Food and Drug Administration.

We have Dr. Tracy Beth Hoag with us today. Dr. Hogue, thank you so much for joining me.

So great to be here, Tudor. Thanks for having me on the show.

I feel like I cannot possibly have enough time with you because there's so much I want to talk about,

but I was looking at your Twitter feed and I was watching some, I guess it was a panel on SSRIs.

And so for people who don't know what those are, that's an antidepressant.

Is that correct?

That's correct. Yes. Selective serotonin re-uptake inhibitors and they're mainly uses antidepressants.

That's correct.

So that conversation was about using them during pregnancy.

And I found it fascinating because I think we as the

public are constantly searching for why are we having some of these changes in our

kids why are we seeing higher rates of autism why are we seeing different rates

of brain development and development in children and one of the doctors

who was on there was saying like if you think that this isn't affecting

the baby's brain, but it is affecting the mom's brain, then you're not really looking at the

research. And that was shocking to me. Yeah, exactly. And that was Dr. Adam Murado, who said that,

and he is one of the world's leading experts in this topic. And he's also an obstetrician and sees patients daily who are on SSRIs and is very familiar

with this topic.

And it is really important for women to understand that, that if these medications are

affecting the way we think and the way our brain works, then they would also, because they cross

...